Abbott FCA Deal Shows Enforcement Adequacy Quandaries
The U.S. Department of Justice's resolution with Abbott Laboratories announced last month illustrates a recurring question in corporate enforcement: When is a civil enforcement action alone sufficient to address allegedly wrongful...To view the full article, register now.
Already a subscriber? Click here to view full article